Keren Medical

Automatic Suturing Device for Prostate Anastomosis

Health Tech & Life Sciences
Non Active, Sep 2021 ceased to operate

Company Overview

Snapshot

Founded in October 2007 by Dan Sadeh Hochstadter and Ofer Yossepiwitch, Keren Medical operates with 1–10 employees. The company has raised $600,000 across one funding round. In January 2012, Keren Medical secured seed funding from VLX Ventures.

Business overview

Keren Medical develops a surgical instrument designed to automate anastomosis between the bladder and urethra following radical prostatectomy. Its core technology is a disposable device, similar in size to a Foley catheter, that installs and fixates absorbable sutures, eliminating the need for complex manual suturing, particularly in robotic surgery. The company's product, AutoTy, aims to make the procedure safer, faster, and more precise, serving the hospitals and urology sectors within the Health Tech & Life Sciences industry globally.

Company Intelligence Q&A

What is Keren Medical's primary product?
Keren Medical's primary product is AutoTy, an automatic suturing device designed for prostate anastomosis following radical prostatectomy.
When was Keren Medical founded?
Keren Medical was founded in October 2007.
Who are the founders of Keren Medical?
Keren Medical was founded by Dan Sadeh Hochstadter and Ofer Yossepiwitch.
What is the status of Keren Medical?
Keren Medical is currently Non Active, having ceased to operate in September 2021.
What type of funding has Keren Medical received?
Keren Medical received $600,000 in seed funding in January 2012 from VLX Ventures.

External links